Opus Genetics Inc
(IRD)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
by (Cboe BZX)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
[[ item.lastPriceExt ]]
[[ item.priceChangeExt ]]
([[ item.percentChangeExt ]])
[[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 09-2010 | 06-2010 | 03-2010 | 12-2009 | 09-2009 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -11,412 | -11,631 | -8,034 | -2,903 | -4,505 |
| Depreciation Amortization | -36 | -24 | -12 | -43 | -20 |
| Other Working Capital | 420 | 581 | -27 | 511 | 288 |
| Other Operating Activity | 6,462 | 8,097 | 7,024 | -2,712 | 478 |
| Operating Cash Flow | $-4,567 | $-2,978 | $-1,049 | $-5,147 | $-3,759 |
| Cash Flows From Investing Activities | |||||
| Change In Deposits | -429 | 75 | N/A | 3,386 | 3,561 |
| PPE Investments | -4 | -3 | -1 | -18 | -16 |
| Other Investing Activity | 843 | 734 | 116 | -2,026 | -2,101 |
| Investing Cash Flow | $410 | $806 | $115 | $1,342 | $1,445 |
| Cash Flows From Financing Activities | |||||
| Common Stock Issued | 12,689 | 12,689 | 1,318 | 10,734 | 6,086 |
| Financing Cash Flow | $12,689 | $12,689 | $1,318 | $10,734 | $6,086 |
| Beginning Cash Position | 7,298 | 7,298 | 7,298 | 369 | 369 |
| End Cash Position | 15,830 | 17,815 | 7,682 | 7,298 | 4,141 |
| Net Cash Flow | $8,532 | $10,517 | $384 | $6,929 | $3,772 |
| Free Cash Flow | |||||
| Operating Cash Flow | -4,567 | -2,978 | -1,049 | -5,147 | -3,759 |
| Capital Expenditure | -4 | -3 | -1 | -18 | -16 |
| Free Cash Flow | -4,571 | -2,981 | -1,050 | -5,165 | -3,774 |